EC
IMDZ

EcoR1 Capital’s Immune Design Corp. IMDZ Stock Holding History

EcoR1 Capital’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,603,191
Closed -$7.28M – 62
2018
Q4 		$7.28M Buy
5,603,191
+3,361,291
+150% +$5.84M 0.73% 37
2018
Q3 		$7.74M Sell
2,241,900
-2,195,700
-49% -$8.24M 0.7% 29
2018
Q2 		$20.2M Hold
4,437,600
– – 1.92% 19
2018
Q1 		$14.4M Buy
4,437,600
+875,000
+25% +$3.1M 1.45% 16
2017
Q4 		$13.9M Buy
+3,562,600
New +$19.4M 1.56% 15

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

EcoR1 Capital's IMDZ Position: Q1 2019 in Review

EcoR1 Capital sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 5,603,191 shares — an estimated $7.28M sold.

EcoR1 Capital first reported a position in IMDZ in Q4 2017 and held it in 5 quarters. The position peaked at $20.2M in Q2 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • EcoR1 Capital reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • EcoR1 Capital sold 5,603,191 Immune Design Corp. shares in Q1 2019, an estimated $7.28M.
  • EcoR1 Capital first reported a position in Immune Design Corp. in Q4 2017 and held it in 5 quarters.
  • EcoR1 Capital's Immune Design Corp. position peaked at $20.2M in Q2 2018.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on EcoR1 Capital's 13F filing for Q1 2019, filed 15 May 2019.